Based on the finding that reovirus treatment induces PD-L1 expression, a Phase I trial of intravenous reovirus and pembrolizumab in addition to chemotherapy with eleven patients suffering from pancreatic cancer was initiated. Here, CD274 is linked to familial pancreatic carcinoma.